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Abstract 
Background: Maximal sterile barrier precautions (MSBP) including head coverings and face masks are advocated 
for use in invasive procedures, including coronary interventions. The rationale for MSBP assumes it is an obligatory 
measure for infection prevention. However, in many coronary catheterization laboratories, head coverings/face masks 
are not used in daily practice. This study prospectively evaluated the potential hazards of not routinely using head 
coverings/face masks in routine coronary interventions.
Methods: This is a prospective study of ambulatory patients in hospital care. A total of 110 successive elective 
patients undergoing cardiac catheterizations were recruited. Patients were catheterized by several interventional car‑
diologists who employed only routine infection control precautions without head coverings or face masks. For each 
patient, we took blood cultures and cultures from the tips of the coronary catheters and from the sterile saline water 
flush bowl. Cultures were handled and analyzed at our certified hospital microbiology laboratory.
Results: In none of the cultures was a clinically significant bacterial growth isolated. No signs of infection were 
reported later by any of the study patients and there were no relevant subsequent admissions.
Conclusion: Operating in the catheterization lab without head coverings/face masks was not associated with any 
bacterial infection in multiple blood and equipment cultures. Accordingly, we believe that the use of head coverings/
face masks should not be an obligatory requirement and may be used at the interventional cardiologist’s discretion.
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Background
Maximal sterile barrier precautions (MSBP) including 
head coverings and face masks are advocated by pub-
lished guidelines for use in invasive procedures related 
to intravascular catheter placement and replacement 
[1]. The rationale for MSBP is that it protects both the 
operator and the patient from infection transmission 
[2]. Accordingly, the use of MSBP, including the use of a 
cap, mask, sterile gown, sterile gloves, and a sterile full 
body drape, for intravascular catheter insertion and/or 
guide wire exchange was recommended as category IB 
[1, 3]. The original coronary catheterization laboratory 
(cath lab) procedure in the 1970s involved brachial artery 
cut-downs and was, therefore, considered an operation 
requiring complete sterile technique. In 2006, the Soci-
ety for Cardiac Angiography and Interventions (SCAI) 
published infection control guidelines for the cath lab. 
These SCAI infection control guidelines indicated that 
for patient preparation, aseptic technique requires the 
use of cap, mask, sterile gown, sterile gloves, and large 
sterile sheet [4]. The cardiac cath lab has evolved since, 
but remains a complex environment in which implant-
able devices, closure devices, and other equipment must 
be used in a secure sterile fashion. In defining recent cath 
lab protocol, infection control issues generated much 
expert discussion as the Joint Commission considered 
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than a clean one. Eventually, the 2012 American College 
of Cardiology Foundation/Society for Cardiovascular 
Angiography and Interventions expert consensus docu-
ment on cardiac catheterization laboratory standards 
update noted that it is reasonable to wear hats and masks 
in the cath lab, but they are not mandated except for cer-
tain high-risk procedures—those involving insertion of 
devices, such as prosthetic valves and electrophysiology 
devices, and to close septal defects and patent foramen 
ovale. In these cases it was recommended that each labo-
ratory should have a written protocol for increased sterile 
technique for highly infectious cases that should include 
caps, masks, double gloving, and protective eyewear [5]. 
In general, infectious complications in the cath lab are 
rare, ranging between 0.1 and 0.6% [6]. However, previ-
ous reports did suggest that infection transmission may 
be relevant for interventions done in the cath lab and that 
implementation of “full dressing” protocols decreases 
vascular catheter-related infection [7, 8]. In contrast, 
there is no evidence that rates increase without the use 
of hats and masks. This may explain the “daily practice” 
in which the many of interventional cardiologists in both 
the USA and Europe do not use head coverings and face 
masks. To clarify this debate and the struggle between 
regulatory instructions and daily practice, the purpose of 
the current study was to perform a systematic and thor-
ough microbiological analysis in assessing the potential 
hazards of not using head coverings/face masks in per-
cutaneous coronary interventions done routinely in the 
cath lab. To the best of our knowledge such a study in 




A total of 110 successive ambulatory patients undergoing 
elective cardiac catheterizations were recruited. Patient 
characteristics are elaborated in Table 1.
Patients were catheterized by several interventional 
cardiologists who employed only routine infection 
control precautions of standard hand washing, sterile 
gloves, and gowns without head coverings or face masks. 
All the procedures were diagnostic coronary angiograms 
and/or percutaneous coronary interventions. Exclusion 
criteria were: an index procedure for anti-arrhythmic 
device implantation or closure device, hemodialysis, pre-
vious catheters (temporal or permanent), active chemo-
therapy treatment, known immunosuppression status, 
or any recent history of febrile illness and/or antibiotic 
treatment. In each patient, at the end of the procedure in 
the cath lab, we took two sets of blood cultures (aerobic 
and anaerobic), one from a peripheral venous blood sam-
ple and one from the introducer arterial sheath inserted 
for the catheterization procedure. In addition, cultures 
were taken from the tips of the coronary procedure 
catheters and from the sterile saline water flush bowl. 
The study was approved by the IRB of the Poriya Medi-
cal Center, Tiberias, Israel. All patients signed a written 
informed consent prior to their participation.
Microbiology workup
Cultures were handled and analyzed at our certified hos-
pital microbiology laboratory. All blood cultures were 
incubated for a period of 7  days in BACTECTM FX 
(BD Diagnostics, Sparks, MD). This system is designed 
to detect microbial growth from blood specimens by 
measuring released CO2 produced through microorgan-
isms’ metabolism. In case of a positive blood culture, a 
Gram stain would be performed for microorganism iden-
tification in accordance with its morphology and a cul-
ture would be made on a solid growth media for later 
microorganism identification by colony morphology 
characteristics. In addition, tips of catheters were sent 
to the clinical microbiology laboratory for microorgan-
ism colony identification and were seeded using sterile 
tweezers on blood agar plates with 5% sheep blood (BD 
Diagnostics, Sparks, MD). The water solution that was 
sent to the laboratory was spun in a centrifuge for 10 min 
at 3000  rpm and the sediment was seeded on blood 
agar growth media. All cultures were incubated 48  h at 
37 °C. Each suspected bacterial growth was characterized 
by the VITEK 2 system (bioMérieux, Durham, NC), an 
automated system for bacterial identification.
Results
Out of a total of 440 blood culture samples that were 
collected from 110 patients enrolled in the study, six 
were positive (1.3%). None of the patients enrolled in 
the study had more than one positive blood culture. All 
positive blood culture samples were aerobic in nature 
and presented coagulase-negative Staphylococcus (CoNS) 
growth. There was no bacterial growth in all the cultures 
collected from the ends of catheters and rinsing fluid. 
Table 1 General characteristics of patients
Parameter Descriptive statistics n = 110
Age, mean ± SD 57.9 ± 12.4
Man, n (%) 88 (80.0)
Diabetes mellitus, n (%) 42 (38.2)
Hypertension, n (%) 70 (63.6)
Permanent pacemaker, n (%) 6 (5.5)
PCI, n (%) 72 (65.5)
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Further clinical follow-up of the patients demonstrated 
that none of the patients had developed any systemic 
signs of bacteremia or local infection proximate to area 
where the catheters were inserted.
Discussion
The main finding of our current study is that not using 
full MSBP, specifically head coverings and face masks, 
is not associated with any clinically significant bacterial 
growth in either blood cultures, catheter tips, or sterile 
saline solution cultures. In addition, no clinical systemic 
or local infection was noted. To the best of our knowl-
edge, this is the first study done in modern cath lab daily 
practice that focuses on a thorough microbiological 
assessment of such an important clinical question. Our 
current data support the daily practice of many inter-
ventional cardiologists in routine daily procedures done 
in the cath lab—not to use head covering and/or face 
mask as a measure for infection prevention. Our current 
study also supports current guidelines, which label these 
measures as a reasonable option rather than an obliga-
tory one [5]. In this study, all cases of positive blood 
culture showed only in one bottle out of a set of bottles 
taken from the same area of each patient. This finding is 
in addition to coagulase-negative Staphylococcus growth, 
which is part of the normal skin flora, [9] probably due 
to wrong sample taking and lack of antiseptic technique 
use by the staff and not an infection that developed dur-
ing the procedure [10–12]. Although the strict sterile 
techniques used in the operating room are not neces-
sary for most cardiac cath lab procedures, Health Safety 
Guidelines and Usual Precaution Guidelines suggest that 
masks, an eye shield, and protective caps should be worn 
during cardiac catheterization as part of the sterile access 
field preservation [4]. This is why conflicts may occur 
between regulatory supervision bodies and the daily 
practice in many cath labs. We believe that our current 
analysis may clarify the safety of such practice and it will 
be decided by each interventional cardiologist’s discre-
tion rather than by regulatory obligation. The main limi-
tation of our study is the lack of a control arm. Indeed, it 
was our original intention to compare the results half way 
through the study of not using MSBP with a control arm 
of a routine use of MSBP. However, as we realized dur-
ing the study itself that no clinically significant positive 
cultures emerged, we decided to continue with disuse of 
MSBP for the rest of the study. In summary, we demon-
strated a thorough microbiological survey in 110 elec-
tive patients who had routine procedures in the cath lab, 
none of whom had any negative microbiological clinical 
consequences from the practice of not using head cover-
ings or face masks routinely.
Conclusion
Operating in the catheterization lab without head cov-
erings/face masks was not associated with any bacte-
rial infection in multiple blood and equipment cultures. 
Accordingly, we believe that the use of head coverings/
face masks should not be an obligatory requirement 
and may be used at the interventional cardiologist’s 
discretion.
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